Global Cancer Gene Therapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
SKU ID :GIR-12974458 | Published Date: 16-Oct-2018 | No. of pages: 129Description
TOC
Table of Contents
1 Cancer Gene Therapy Market Overview
1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Classification of Cancer Gene Therapy by Types
1.2.1 Global Cancer Gene Therapy Revenue Comparison by Types (2017-2023)
1.2.2 Global Cancer Gene Therapy Revenue Market Share by Types in 2017
1.2.3 Oncolytic Virotherapy
1.2.4 Gene Transfer
1.2.5 Gene-Induced Immunotherapy
1.3 Global Cancer Gene Therapy Market by Application
1.3.1 Global Cancer Gene Therapy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Global Cancer Gene Therapy Market by Regions
1.4.1 Global Cancer Gene Therapy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cancer Gene Therapy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Gene Therapy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Gene Therapy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Gene Therapy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Gene Therapy Status and Prospect (2013-2023)
1.5 Global Market Size of Cancer Gene Therapy (2013-2023)
2 Manufacturers Profiles
2.1 Adaptimmune
2.1.1 Business Overview
2.1.2 Cancer Gene Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Adaptimmune Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bluebird bio
2.2.1 Business Overview
2.2.2 Cancer Gene Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bluebird bio Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
2.3.1 Business Overview
2.3.2 Cancer Gene Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Shanghai Sunway Biotech
2.4.1 Business Overview
2.4.2 Cancer Gene Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Shenzhen SiBiono GeneTech
2.5.1 Business Overview
2.5.2 Cancer Gene Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 SynerGene Therapeutics
2.6.1 Business Overview
2.6.2 Cancer Gene Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 SynerGene Therapeutics Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Altor BioScience
2.7.1 Business Overview
2.7.2 Cancer Gene Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Altor BioScience Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.8 Amgen
2.8.1 Business Overview
2.8.2 Cancer Gene Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Amgen Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.9 Argenx
2.9.1 Business Overview
2.9.2 Cancer Gene Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Argenx Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.10 BioCancell
2.10.1 Business Overview
2.10.2 Cancer Gene Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 BioCancell Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.11 GlaxoSmithKline
2.11.1 Business Overview
2.11.2 Cancer Gene Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.12 Merck
2.12.1 Business Overview
2.12.2 Cancer Gene Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.13 OncoGenex Pharmaceuticals
2.13.1 Business Overview
2.13.2 Cancer Gene Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.14 Transgene
2.14.1 Business Overview
2.14.2 Cancer Gene Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Transgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Gene Therapy Market Competition, by Players
3.1 Global Cancer Gene Therapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Gene Therapy Players Market Share
3.2.2 Top 10 Cancer Gene Therapy Players Market Share
3.3 Market Competition Trend
4 Global Cancer Gene Therapy Market Size by Regions
4.1 Global Cancer Gene Therapy Revenue and Market Share by Regions
4.2 North America Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
4.3 Europe Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
4.5 South America Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
5 North America Cancer Gene Therapy Revenue by Countries
5.1 North America Cancer Gene Therapy Revenue by Countries (2013-2018)
5.2 USA Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
5.3 Canada Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
6 Europe Cancer Gene Therapy Revenue by Countries
6.1 Europe Cancer Gene Therapy Revenue by Countries (2013-2018)
6.2 Germany Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
6.3 UK Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
6.4 France Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
6.5 Russia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
6.6 Italy Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Gene Therapy Revenue by Countries
7.1 Asia-Pacific Cancer Gene Therapy Revenue by Countries (2013-2018)
7.2 China Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
7.3 Japan Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
7.4 Korea Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
7.5 India Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
8 South America Cancer Gene Therapy Revenue by Countries
8.1 South America Cancer Gene Therapy Revenue by Countries (2013-2018)
8.2 Brazil Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cancer Gene Therapy by Countries
9.1 Middle East and Africa Cancer Gene Therapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
9.3 UAE Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
10 Global Cancer Gene Therapy Market Segment by Type
10.1 Global Cancer Gene Therapy Revenue and Market Share by Type (2013-2018)
10.2 Global Cancer Gene Therapy Market Forecast by Type (2018-2023)
10.3 Oncolytic Virotherapy Revenue Growth Rate (2013-2023)
10.4 Gene Transfer Revenue Growth Rate (2013-2023)
10.5 Gene-Induced Immunotherapy Revenue Growth Rate (2013-2023)
11 Global Cancer Gene Therapy Market Segment by Application
11.1 Global Cancer Gene Therapy Revenue Market Share by Application (2013-2018)
11.2 Cancer Gene Therapy Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Diagnostics Centers Revenue Growth (2013-2018)
11.5 Research Institutes Revenue Growth (2013-2018)
12 Global Cancer Gene Therapy Market Size Forecast (2018-2023)
12.1 Global Cancer Gene Therapy Market Size Forecast (2018-2023)
12.2 Global Cancer Gene Therapy Market Forecast by Regions (2018-2023)
12.3 North America Cancer Gene Therapy Revenue Market Forecast (2018-2023)
12.4 Europe Cancer Gene Therapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cancer Gene Therapy Revenue Market Forecast (2018-2023)
12.6 South America Cancer Gene Therapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cancer Gene Therapy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Tables & Figures
List of Tables and Figures
Figure Cancer Gene Therapy Picture
Table Product Specifications of Cancer Gene Therapy
Table Global Cancer Gene Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Gene Therapy Revenue Market Share by Types in 2017
Figure Oncolytic Virotherapy Picture
Figure Gene Transfer Picture
Figure Gene-Induced Immunotherapy Picture
Table Global Cancer Gene Therapy Revenue (Million USD) by Application (2013-2023)
Figure Cancer Gene Therapy Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Diagnostics Centers Picture
Figure Research Institutes Picture
Table Global Market Cancer Gene Therapy Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Table Adaptimmune Basic Information, Manufacturing Base and Competitors
Table Adaptimmune Cancer Gene Therapy Type and Applications
Table Adaptimmune Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Bluebird bio Basic Information, Manufacturing Base and Competitors
Table Bluebird bio Cancer Gene Therapy Type and Applications
Table Bluebird bio Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cancer Gene Therapy Type and Applications
Table Celgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Shanghai Sunway Biotech Basic Information, Manufacturing Base and Competitors
Table Shanghai Sunway Biotech Cancer Gene Therapy Type and Applications
Table Shanghai Sunway Biotech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Shenzhen SiBiono GeneTech Basic Information, Manufacturing Base and Competitors
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Type and Applications
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table SynerGene Therapeutics Basic Information, Manufacturing Base and Competitors
Table SynerGene Therapeutics Cancer Gene Therapy Type and Applications
Table SynerGene Therapeutics Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Altor BioScience Basic Information, Manufacturing Base and Competitors
Table Altor BioScience Cancer Gene Therapy Type and Applications
Table Altor BioScience Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Gene Therapy Type and Applications
Table Amgen Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Argenx Basic Information, Manufacturing Base and Competitors
Table Argenx Cancer Gene Therapy Type and Applications
Table Argenx Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table BioCancell Basic Information, Manufacturing Base and Competitors
Table BioCancell Cancer Gene Therapy Type and Applications
Table BioCancell Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Cancer Gene Therapy Type and Applications
Table GlaxoSmithKline Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cancer Gene Therapy Type and Applications
Table Merck Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table OncoGenex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Type and Applications
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Transgene Basic Information, Manufacturing Base and Competitors
Table Transgene Cancer Gene Therapy Type and Applications
Table Transgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cancer Gene Therapy Revenue (Million USD) by Players (2013-2018)
Table Global Cancer Gene Therapy Revenue Share by Players (2013-2018)
Figure Global Cancer Gene Therapy Revenue Share by Players in 2016
Figure Global Cancer Gene Therapy Revenue Share by Players in 2017
Figure Global Top 5 Players Cancer Gene Therapy Revenue Market Share in 2017
Figure Global Top 10 Players Cancer Gene Therapy Revenue Market Share in 2017
Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Cancer Gene Therapy Revenue (Million USD) by Regions (2013-2018)
Table Global Cancer Gene Therapy Revenue Market Share by Regions (2013-2018)
Figure Global Cancer Gene Therapy Revenue Market Share by Regions (2013-2018)
Figure Global Cancer Gene Therapy Revenue Market Share by Regions in 2017
Figure North America Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Europe Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure South America Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Table North America Cancer Gene Therapy Revenue by Countries (2013-2018)
Table North America Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Cancer Gene Therapy Revenue Market Share by Countries in 2017
Figure USA Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Canada Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Mexico Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Table Europe Cancer Gene Therapy Revenue (Million USD) by Countries (2013-2018)
Figure Europe Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Europe Cancer Gene Therapy Revenue Market Share by Countries in 2017
Figure Germany Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure UK Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure France Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Russia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Italy Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cancer Gene Therapy Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Cancer Gene Therapy Revenue Market Share by Countries in 2017
Figure China Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Japan Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Korea Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure India Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Table South America Cancer Gene Therapy Revenue by Countries (2013-2018)
Table South America Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Cancer Gene Therapy Revenue Market Share by Countries in 2017
Figure Brazil Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Argentina Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Colombia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cancer Gene Therapy Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Gene Therapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure UAE Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Egypt Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure Nigeria Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Figure South Africa Cancer Gene Therapy Revenue and Growth Rate (2013-2018)
Table Global Cancer Gene Therapy Revenue (Million USD) by Type (2013-2018)
Table Global Cancer Gene Therapy Revenue Share by Type (2013-2018)
Figure Global Cancer Gene Therapy Revenue Share by Type (2013-2018)
Figure Global Cancer Gene Therapy Revenue Share by Type in 2017
Table Global Cancer Gene Therapy Revenue Forecast by Type (2018-2023)
Figure Global Cancer Gene Therapy Market Share Forecast by Type (2018-2023)
Figure Global Oncolytic Virotherapy Revenue Growth Rate (2013-2018)
Figure Global Gene Transfer Revenue Growth Rate (2013-2018)
Figure Global Gene-Induced Immunotherapy Revenue Growth Rate (2013-2018)
Table Global Cancer Gene Therapy Revenue by Application (2013-2018)
Table Global Cancer Gene Therapy Revenue Share by Application (2013-2018)
Figure Global Cancer Gene Therapy Revenue Share by Application (2013-2018)
Figure Global Cancer Gene Therapy Revenue Share by Application in 2017
Table Global Cancer Gene Therapy Revenue Forecast by Application (2018-2023)
Figure Global Cancer Gene Therapy Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Diagnostics Centers Revenue Growth Rate (2013-2018)
Figure Global Research Institutes Revenue Growth Rate (2013-2018)
Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Cancer Gene Therapy Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Cancer Gene Therapy Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Cancer Gene Therapy Revenue Market Forecast (2018-2023)
Figure Europe Cancer Gene Therapy Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Cancer Gene Therapy Revenue Market Forecast (2018-2023)
Figure South America Cancer Gene Therapy Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Cancer Gene Therapy Revenue Market Forecast (2018-2023)
Companies
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
- PRICE
-
$3480$6960